← Back
Data updated: Mar 10, 2026
BEDFORD LABS
OncologyInfectious DiseaseCardiovascular
BEDFORD LABS is a generic drug manufacturer focused on Oncology, Infectious Disease, Cardiovascular. Key products include CEFAZOLIN SODIUM.
1982
Since
25
Drugs
-
Trials
206
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
CEFAZOLIN SODIUM 2026-02-13
Efficacy
FLUOROURACIL 2026-02-10
Labeling
SULFAMETHOXAZOLE AND TRIMETHOPRIM 2026-02-10
Labeling
FLUOROURACIL 2026-02-10
Labeling
FLUOROURACIL 2026-02-05
Labeling
FLUOROURACIL 2026-02-05
Labeling
FLUOROURACIL 2026-02-05
Labeling
FLUOROURACIL 2026-02-05
Labeling
FLUOROURACIL 2026-02-05
Labeling
FLUOROURACIL 2026-02-05
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 33%
2 drugs
Infectious Disease 17%
1 drugs
Cardiovascular 17%
1 drugs
Gastroenterology 17%
1 drugs
Dermatology 17%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Dermatology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Oncology
CASPER PHARMA LLC big-pharma
Infectious Disease, Oncology, Cardiovascular, Gastroenterology, Dermatology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology, Cardiovascular
Active (10)
Discontinued (14)
CEFAZOLIN SODIUM SULFAMETHOXAZOLE AND TRIMETHOPRIM LORAZEPAM DESMOPRESSIN ACETATE METOCLOPRAMIDE HYDROCHLORIDE METHYLPREDNISOLONE SODIUM SUCCINATE PROMETHAZINE HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER CIPROFLOXACIN ADENOSINE LORAZEPAM PRESERVATIVE FREE NEOSAR DESMOPRESSIN ACETATE PRESERVATIVE FREE
Company Info
- First Approval
- 1982-02-16
- Latest
- 2014-12-02
- Applications
- 32
FDA Sponsor Names
BEDFORD LABSBEDFORD